TY - JOUR
T1 - The course of psychopathologic features in mild to moderate Alzheimer disease
AU - Devanand, D. P.
AU - Jacobs, Diane M.
AU - Tang, Ming Xin
AU - Castillo-Castaneda, Caridad Del
AU - Sano, Mary
AU - Marder, Karen
AU - Bell, Karen
AU - Bylsma, Frederick W.
AU - Brandt, Jason
AU - Albert, Marilyn
AU - Stern, Yaakov
N1 - Funding Information:
This work was supported in part by federal grants AG07370,AG08702,andRR00645fromtheNationalIn¬ stitute onAgingofHealth,Bethesda,andMH44176andMH50038fromMd;the
Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 1997
Y1 - 1997
N2 - Background: The onset and course of the psychopathologic features of Alzheimer disease have not been established in prospective, longitudinal studies. Methods: Two hundred thirty-five patients with early, probable Alzheimer disease were recruited at 3 sites and observed naturalistically for up to 5 years. At 6-month intervals, the Columbia University Scale for Psychopathology in Alzheimer's Disease was administered. Markov analyses were used to predict the probability of a specific symptom developing or being maintained at the next visit. For each symptom category, the maximum frequency of occurrence at 4 consecutive points (duration, 2 years) was calculated. Results: Misidentification, wandering or agitation, and physical aggression increased during follow-up. At any visit, the likelihood of a new symptom developing was greatest for behavioral disturbance, intermediate for paranoid delusions and hallucinations, and least for depressed mood with vegetative features. Wandering or agitation occurred at 3 or more of 4 consecutive visits (duration, 2 years) in the majority of patients, paranoid delusions and hallucinations were intermediate in their degree of persistence, and depressed mood with vegetative signs rarely persisted. Conclusions: Behavioral disturbance, particularly agitation, is common and persistent in patients with Alzheimer disease. Psychotic symptoms are less common and show moderate persistence over time. Depressed mood with vegetative signs is uncommon and rarely persists. These findings suggest leads about the optimal treatment duration for specific subtypes of psychopathologic features.
AB - Background: The onset and course of the psychopathologic features of Alzheimer disease have not been established in prospective, longitudinal studies. Methods: Two hundred thirty-five patients with early, probable Alzheimer disease were recruited at 3 sites and observed naturalistically for up to 5 years. At 6-month intervals, the Columbia University Scale for Psychopathology in Alzheimer's Disease was administered. Markov analyses were used to predict the probability of a specific symptom developing or being maintained at the next visit. For each symptom category, the maximum frequency of occurrence at 4 consecutive points (duration, 2 years) was calculated. Results: Misidentification, wandering or agitation, and physical aggression increased during follow-up. At any visit, the likelihood of a new symptom developing was greatest for behavioral disturbance, intermediate for paranoid delusions and hallucinations, and least for depressed mood with vegetative features. Wandering or agitation occurred at 3 or more of 4 consecutive visits (duration, 2 years) in the majority of patients, paranoid delusions and hallucinations were intermediate in their degree of persistence, and depressed mood with vegetative signs rarely persisted. Conclusions: Behavioral disturbance, particularly agitation, is common and persistent in patients with Alzheimer disease. Psychotic symptoms are less common and show moderate persistence over time. Depressed mood with vegetative signs is uncommon and rarely persists. These findings suggest leads about the optimal treatment duration for specific subtypes of psychopathologic features.
UR - http://www.scopus.com/inward/record.url?scp=14444273255&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=14444273255&partnerID=8YFLogxK
U2 - 10.1001/archpsyc.1997.01830150083012
DO - 10.1001/archpsyc.1997.01830150083012
M3 - Article
C2 - 9075466
AN - SCOPUS:14444273255
SN - 2168-622X
VL - 54
SP - 257
EP - 263
JO - JAMA Psychiatry
JF - JAMA Psychiatry
IS - 3
ER -